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ABSTRACT
The DNA of patients taking immunosuppressive
and anti-inflammatory thiopurines contains
6-thioguanine (6-TG) and their skin is hypersensitive
to ultraviolet A (UVA) radiation. DNA 6-TG absorbs
UVA and generates reactive oxygen species that
damage DNA and proteins. Here, we show that the
DNA damage includes covalent DNA–protein
crosslinks. An oligonucleotide containing a single
6-TG is photochemically crosslinked to cysteine-
containing oligopeptides by low doses of UVA.
Crosslinking is significantly more efficient if guanine
sulphonate (G
SO3)—an oxidized 6-TG and a previ-
ously identified UVA photoproduct—replaces 6-TG,
suggesting that G
SO3 is an important reaction inter-
mediate. Crosslinking occurs via oligopeptide
sulphydryl and free amino groups. The oligonucleo-
tide–oligopeptide adducts are heat stable but are
partially reversed by reducing treatments. UVA
irradiation of human cells containing DNA 6-TG
induces extensive heat- and reducing agent-
resistant covalent DNA–protein crosslinks and
diminishes the recovery of some DNA repair and
replication proteins from nuclear extracts. DNA–
protein crosslinked material has an altered buoyant
density and can be purified by banding in ces-
ium chloride (CsCl) gradients. PCNA, the MSH2
mismatch repair protein and the XPA nucleotide
excision repair (NER) factor are among the proteins
detectable in the DNA-crosslinked material. These
findings suggest that the 6-TG/UVA combination
might compromise DNA repair by sequestering
essential proteins.
INTRODUCTION
Since their development >50 years ago, thiopurine
pro-drugs have been widely used as immunosuppressants
and in cancer therapy. They are now increasingly
prescribed in the treatment of chronic relapsing inﬂamma-
tory disorders such as inﬂammatory bowel disease.
Azathioprine, the most extensively prescribed immuno-
suppressant in organ transplant patients, is classed as a
human carcinogen by IARC (1). This designation reﬂects
the 100- to 200-fold increased incidence of skin cancer that
accompanies long-term azathioprine use following organ
transplantation (2,3). Although epidemiological evidence
implicates both the duration of immunosuppression and
sunshine exposure in this hugely increased cancer risk, the
way that these factors interact in the development of skin
cancer remains unclear.
The end products of thiopurine metabolism,
6-thioguanine (6-TG) nucleotides, are substrates for
incorporation into nucleic acids and the DNA of
azathioprine patients accumulates measurable amounts
of 6-TG (4–6). Unlike the canonical DNA bases, 6-TG
absorbs ultraviolet A (UVA) and DNA 6-TG is photo-
chemically activated by wavelengths around 340nm to
generate singlet oxygen (
1O2) (7), a form of reactive
oxygen species (ROS) that can damage both DNA and
proteins (6,8). UVA comprises >90% of the ultraviolet
radiation in incident sunlight and the skin of patients
receiving azathioprine is hypersensitive to simulated
sunlight and to UVA, but not to UVB (6,9). This UVA
hypersensitivity is consistent with the formation of DNA
photodamage in skin although the nature of this damage
remains incompletely deﬁned. To obtain a better under-
standing of the UVA sensitivity of DNA in azathioprine
patients and whether photochemical DNA lesions might
contribute to their skin cancer risk, we are investigating
photochemical reactions of DNA 6-TG.
Work in model cell culture systems has established that
1O2 generated from DNA 6-TG is hazardous. Low doses
of UVA are mutagenic and extremely toxic to cells con-
taining DNA 6-TG (6). At the molecular level, the low
oxidation potential of DNA 6-TG makes it a preferred
target and DNA-generated ROS cause its rapid oxidation
to guanine sulphinate (G
SO2) and guanine sulphonate
(G
SO3) (10). Both these DNA 6-TG oxidation products
are potent blocks to replication and transcription in vitro
(7,11). The vulnerability of DNA containing 6-TG is
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single and double strand—by low doses of UVA. S-phase
cells are particularly vulnerable, in this regard, and some
or all of the 6-TG/UVA induced DNA lesions trigger
DNA damage responses and associated cell cycle check-
points (12).
ROS generated from DNA 6-TG also damage proteins.
1O2 targets the histidine and aromatic residues of proteins
(13,14). Consistent with these reaction preferences,
subunits of the Proliferating cell nuclear antigen
(PCNA) replication processivity factor become covalently
crosslinked via histidine in cells treated with 6-TG and
UVA (6,8). This efﬁcient PCNA crosslinking suggested
that DNA-associated proteins might be particularly sus-
ceptible to photochemical damage involving DNA 6-TG.
PCNA clamps replication factors to DNA by encircling
the DNA helix. Many DNA processing proteins, including
RNA polymerase II (15,16) and the mismatch recognition
factor MutSa (17), employ similar strategies. The particu-
larly intimate DNA–protein contact involved in these
interactions might render these proteins exceptionally vul-
nerable to DNA-generated ROS. Here, we demonstrate
that DNA 6-TG interacts with UVA to cause rapid
covalent attachment of proteins to DNA. This is
observed in vitro in reactions between oligopeptides and
6-TG containing oligonucleotides and in vivo as the
covalent attachment of nuclear proteins to DNA of
UVA irradiated cultured cells. DNA repair and replica-
tion factors are identiﬁed among the crosslinked proteins.
This raises the possibility that these processes may be
compromized by photochemical reactions of DNA 6-TG.
MATERIALS AND METHODS
Cell culture and chemicals
Human mismatch-repair deﬁcient (MLH1) defective (18)
CCRF-CEM leukaemia cells were grown in RPMI, sup-
plemented with 10% fetal calf serum. Chemicals were
purchased from Sigma-Aldrich (St Louis, MO, USA)
unless otherwise stated. Cells were radiolabelled by over-
night incubation with 2-[
14C]-thymidine at 0.1mCi/ml
(Perkin Elmer, Waltham, MA, USA). UVA irradiations
were performed as described before (8).
2D-DIGE
Materials, apparatus and software were all from GE
Healthcare (Piscataway, NJ, USA). Quadruplicate inde-
pendent nuclear extracts (50mg protein) of cells that had
received the same 6-TG/UVA treatment were labelled
with 0.4pmol Cy3/Cy5 CyDye. For the ﬁrst dimension,
150mg of CyDye labelled proteins were cuploaded onto
rehydrated IEF pH 3-7 NL Immobiline DryStrip strips.
Isoelectric focusing was performed on an Ettan IPGphor
IEF system using the Ettan IPGphor cup loading
manifold. Following IEF, the second dimension separ-
ation was carried out on 12% polyacrylamide gels.
Fluorescently labelled proteins were visualized using a
Typhoon 9400 variable mode imager and Typhoon
scanner control software, version 3.0. All images were
cropped using ImageQuant tools to exclude non-essential
information prior to DeCyder analysis. Analysis of gel
images was performed using DeCyder differential
analysis software version 6.5. Protein spots with a
1.5-fold difference in abundance and a Student’s t-test
value of P 0.01 were selected. Preparative gels for spot
picking were stained using 0.1% colloidal coomassie blue
G-250 (Sigma Aldrich) for 4 days. Protein spots of interest
were manually excised from the stained gels.
Mass spectrometry
Peptides for analysis were generated by in situ tryptic di-
gestion of protein/gel bands. LC-MS/MS analysis of the
peptides was carried out on a LTQ Orbitrap XL/ETD
mass spectrometer (ThermoScientiﬁc, Waltham, MA,
USA) and the data searched against a concatenated,
non-redundant protein database (UniProt KB15.5),
using the Mascot search engine (Matrix Science,
London, UK).
Genomic DNA preparation
Cells were treated for 48h with 0.8mM 6-TG in complete
medium. After irradiation, they were transferred to
Eppendorf tubes and lysed by addition of three pellet
volumes of Buffer 1 (10mM Tris–HCl pH 7.4, 2.5mM
MgCl2, 0.5% NP40, 1mM DTT) containing protease in-
hibitors (Roche, Basel, Switzerland). After 10min on ice,
the sample was centrifuged at 10000rpm for 10min and
the pellet was re-suspended in 3 pellet volumes of Buffer 2
(25mM sodium phosphate pH 7.4, 0.5M NaCl, 1mM
EDTA, 0.5% Triton X-100, 10% Glycerol, 5mM
MgCl2, 1mM DTT) containing protease inhibitors.
After a further 30min on ice, the sample was centrifuged
for 20min and the supernatant (the soluble chromatin
fraction) was retained. The pellet was washed twice in
Buffer 2 and ﬁnally resuspended in 400ml of the same
buffer. The sample (containing DNA and associated
proteins) was extensively sheared by passage 20 times
through a 19-gauge needle, then a 21-gauge and ﬁnally
through a 23-gauge needle.
Isopycnic cesium chloride gradient analysis
The sheared DNA sample (100mg) was mixed with 13ml
of cesium chloride (CsCl) solution in TE (starting density
of 1.4, unless indicated) and centrifuged at 60000rpm for
16h at 4 C in a Beckman Vti70.1 ﬁxed angle rotor.
Fractions were collected from the bottom of the tube.
A
260nm was determined by Nanodrop 2000 (Thermo sci-
entiﬁc) and
14C content by scintillation counting.
In experiments in which gradient fractions were probed
by immunoblotting, cell extracts were prepared in RIPA
buffer and sonicated (Branson soniﬁer: 20 times 0.5s
pulses at 15% power) before DNA banding on CsCl
gradients. Appropriate gradient fractions were pooled
and desalted on PD-10 columns (GE Healthcare
Piscataway, NJ, USA) equilibrated in water. Aliquots
were applied to a N
+ hybond membrane and crosslinked
with UVC. The membranes were probed with antibodies
against PCNA (PC10: Santa Cruz, Santa Cruz, CA,
USA), XPA (Clone 12F5: Abcam, Cambridge, MA,
USA), MSH2 (Clone FE11: Oncogene) CASPASE 5-p20
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Montgomery, TX, USA). Goat and mouse HRP second-
ary antibodies were from Biorad (Hercules, CA, USA).
In vitro crosslinking
The 26-mer oligonucleotide (50-CGATCTGATGTXAGA
GCAGACAGCAG-30 where X=6-thio 20-deoxyguanine)
was purchased from Oligos Etc. (Wilsonville, OR, USA).
When required, the complementary strand in which C was
placed opposite 6-TG was annealed. For oxidation,
1nmol was treated with 1mmol of magnesium monoperox-
yphthalate (MMPP) for 30min at RT followed by ethanol
precipitation and extensive washing. The oxidized
oligonucloetide was incubated with 150nmol oligopeptide
for 16h at 50 C in 50mM Tris pH 7.5. The oligopeptides,
all of which contained a single cysteine, were synthesized
by the in-house CR-UK LRI facility. Their sequences
were as follows:
24-mer: AEIDEDKCIGCGACAEACPTGAIE;
17-mer: PGNGQTAECGATQGNGP; 13-mer: NGQTA
ECGATQGN; 9-mer: QTAECGATQ; 7-mer TAECG
AT; 5-mer: AECGA. Reaction products were separated
on a 16% sequencing gel, excised, extracted and puriﬁed
by precipitation.
RESULTS
DNA–peptide crosslinks in vitro
Previous work (10) established that UVA photoactivated
6-TG forms addition products with low molecular weight
thiol compounds. To investigate whether protein thiols are
similarly vulnerable to photochemical crosslinking to
DNA, we ﬁrst examined the reactions between a synthetic
oligonucleotide and oligopeptides. In initial experiments, a
single-stranded 26-mer oligonucleotide containing 6-TG
was UVA irradiated and incubated with a 7-mer
TAECGAT oligopeptide that contained a single
cysteine. Following overnight incubation at 50 C, a
UVA- and peptide-dependent formation of slowly
migrating products was revealed by denaturing PAGE
analysis (Figure 1A). At 50kJ/m
2 UVA, this product ac-
counted for  10% (average of three experiments;
range=9.3–12.6%) of the input oligonucleotide.
Pre-treatment of the oligonucleotide with MMPP to quan-
titatively convert the 6-TG to G
SO3, signiﬁcantly improved
the reaction efﬁciency and under the same reaction condi-
tions 30–50% of the input oligonucleotide was converted
to the slowly migrating form (Figure 1B). These observa-
tions are consistent with G
SO3, which is a relatively minor
UVA photoproduct but is produced quantitatively by
MMPP treatment, being a likely reaction intermediate.
Similar addition reactions occurred with longer oligo-
peptides. Peptides up to 24-mer, each containing a single
cysteine, were efﬁciently ( 50%) crosslinked to an
oxidized 6-TG oligonucleotide during overnight incuba-
tion at 65 C (Figure 2A). Product yield was increased to
 80% by incubation at 80 C.
Double-stranded 6-TG containing DNA was around
4-fold less reactive than ssDNA at 20 C, and 1.3-fold
less reactive at 50 C, indicating that secondary structural
elements signiﬁcantly inﬂuence the crosslinking reaction
(Figure 2B).
DNA 6-TG crosslinking via peptide thiol and amino
groups
In the majority of products, the 7-mer oligopeptide
(TAECGAT) was crosslinked to the oligonucleotide
through its single cysteine. When serine (S) replaced
cysteine (C), product formation was reduced by  50%
(Figure 3A, lanes 1 and 2) but not abolished. Residual
crosslinking to the TAESGAT oligopeptide was com-
pletely eliminated by acetylation (Ac) of the N-terminal
amino group (lane 3). A similar N-terminal block reduced
crosslinking to TAECGAT by about one-third (lane 4).
These ﬁndings, which are quantiﬁed in Supplementary
Figure S1, suggested the formation of both S-bonded
(via cysteine) and N-bonded (via the free N-terminal
NH2 group) peptide–DNA products. This possibility was
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Figure 1. Crosslinking of a 7-mer TAECGAT peptide to a 26-mer oligonucleotide. (A) 6-TG-containing oligonucleotide was irradiated with the
indicated doses of UVA or oxidized with MMPP before incubation at 50 C with (+) or without ( ) the oligopeptide. After 16h, the reaction
products were resolved by PAGE. Asterisks indicate the major crosslinked species. A minor product is also indicated double asterisks. (B) The
efﬁciency of oligonucleotide crosslinking by UVA- and MMPP-treated oligonucleotides. Data from three independent experiments as described in A
were quantiﬁed by ImageQuant analysis. Mean values are shown and error bars represent the range of values.
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Figure 3. Functional groups involved in crosslinking. (A) MMPP-oxidized 26-mer 6-TG-containing oligo was incubated with 7-mer peptides.
Containing either cysteine (Cys) or serine (Ser). Where indicated, the terminal NH2 group was acetylated (Ac). The peptides are shown schematically
to the right of the gel image. The cysteine thiol (SH) and the serine OH groups are shown. The reaction was allowed to continue for 16h at 65 C and
products resolved by PAGE. The products in lanes 5–8 were treated with reducing agents (100mM DTT, 10% b-mercaptoethanol) for 15min at
95 C before loading. (B) Average crosslinking efﬁciencies, based on at least three experiments. Error bars represent range of values.
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Figure 2. Crosslinking of different peptides to a 6-TG containing oligonucleotide. (A) The 6-TG oligonucleotide was oxidized by MMPP and
incubated for 16h at 65 C with oligopeptides of the length indicated all of which contained a single cysteine. Reaction products were resolved
by PAGE. (B) The MMPP-oxidized 26-mer oligonucleotide was annealed to its complementary (comp) strand as shown and incubated with the
7-mer peptide for 16h at the indicated temperatures. Products were resolved by PAGE. The percentage of crosslinked oligonucleotide indicated at the
top of each lane. The sample in the far left lane is 26-mer oligonucleotide that had been incubated at 50 C in the absence of oligopeptide.
5060 Nucleic Acids Research, 2011,Vol.39, No. 12investigated further by treating the crosslinked species
with reducing agents. Figure 3A (right panel) shows that
the products formed with TAESGAT were impervious to
reducing treatment (lane 5) whereas the same treatment
abolished around two-thirds of crosslinks formed by
TAECGAT (lane 6) or its N-terminally blocked counter-
part (lane 8). In addition to the major crosslinked species
with TAECGAT, we consistently noted a more slowly
migrating species that accounted for 3–5% of the total
(lane 2). This product was also reversed by reducing treat-
ment, compatible with an S–S linkage and was not
formed with TAESGAT. These ﬁndings indicate that
peptides can become either S-bonded or N-bonded to
DNA containing 6-TG. The proposed structures of the
different products are also shown schematically in
Supplementary Figure S1.
Crosslinking in vivo: 2D-DIGE analysis of nuclear
proteins
The efﬁcient crosslinking of peptides to 6-TG-containing
oligonucleotides suggested that covalent attachment of
protein to DNA 6-TG might occur frequently in
UVA-treated cells. This possibility was examined by
2D-DIGE. Brieﬂy, CCRF-CEM cells were allowed to in-
corporate 6-TG for 48h and then irradiated with 10kJ/m
2
UVA. Control cells received 6-TG but were unirradiated.
Nuclear proteins were prepared and derivatized with
ﬂuorescent chromophores. Extracts from irradiated and
unirradiated cells were mixed and analysed by 2D gel elec-
trophoresis. DeCyder 2D software was used to identify
proteins present at signiﬁcantly altered levels in irradiated
cell extracts (a representative gel is shown in
Supplementary Figure S2). Individual proteins were
excised from a separate coomassie-stained gel and
identiﬁed by mass spectrometry. Two examples of the
analysis are shown in Figure 4 and Table 1 summarizes
the nuclear proteins that were reproducibly altered by the
treatment. PCNA provides an internal validation since we
have previously demonstrated that its subunits become
photochemically crosslinked.
Reduced levels of nuclear mismatch repair proteins after
6-TG+UVA treatment
Since the 2-D DIGE screen identiﬁed MSH2, we examined
the effect of 6-TG/UVA on the levels of MSH2 and its
partner protein MSH6 by western blotting. Figure 5A
shows that the recovery from UVA irradiated
CCRF-CEM cells of soluble nuclear MSH2 decreases in
a UVA dose-dependent manner. Parallel experiments
indicated that the reduced recovery was also 6-TG dose
dependent (data not shown). When the post-Triton DNA
fraction (which contains tightly bound proteins) was
sonicated and analysed by western blotting, material
reacting with the MSH2 antibody was detected as a high
molecular weight smear (Figure 5B). Only a small fraction
was present at the expected size of monomeric MSH2.
This suggested that a signiﬁcant fraction of MSH2 was
in the form of high-molecular weight complexes that
were not reversed by the reducing treatment used in
sample preparation.
Combined 6-TG and UVA treatment also affected the
recovery of MSH6, the partner of MSH2 in the MutSa
mismatch recognition heterodimer. Supplementary Figure
S3 shows that the amount of MSH6 recovered from the
triton-soluble fraction decreased in a 6-TG dose-
dependent manner and that this was dependent on
UVA. A similar analysis indicated that MSH6 was also
present in the high-molecular weight DNA-containing
material. Recovery of MSH2 and MSH6 from the cyto-
plasmic fraction was not detectably affected by 6-TG/
UVA treatment (data not shown).
6-TG and UVA induce DNA–protein crosslinks in
genomic DNA
Isopycnic density gradient analysis was used to investigate
possible covalent photochemical crosslinking of nuclear
proteins to DNA. CCRF-CEM cells containing DNA
Table 1. Nuclear proteins with signiﬁcantly altered expression in
6-TG+UVA-treated cells
Average ratio t-test
Down-regulated
DNA damage binding protein 1  2.11 1.50E-03
MSH2
a  2.72 5.40E-05
ATP-dependant helicase 2  2.68 1.50E-04
MCM 6  2.36 8.30E-05
MCM 7  2.25 1.30E-05
PCNA  1.99 1.10E-05
High-mobility protein group 1  3.48 4.00E-03
Programmed cell death 6  1.62 1.10E-03
PARK7  1.55 1.60E-03
Glutathione transferase omega  1.66 2.60E-03
Heterogeneous nuclear ribonucleoprotein H  1.53 1.00E-02
Histone binding protein RBBP4  2.05 1.80E-04
Ubiquitin activating Enzyme UBA2  4.83 1.80E-05
Up-regulated
Prohibitin +2.31 3.10E-04
aMCM3 peptides were also detected in the picked spot but did not
contribute signiﬁcantly (4 peptides, 5% protein coverage as opposed
to 17 peptides, 20% coverage). Criteria for inclusion were: Nuclear
localization. Consistent change in abundance of  1.5-fold. T-test:
P-value  10
 2
PCNA
MSH2 &
MCM3
ar= -1.99 , p= 1.1x10-5 ar= -2.72, p= 5.4x10-5
Figure 4. Examples of proteins with reduced representation on 2-D
gels. Cropped sections of a representative 2D DIGE gel. 6-TG
(green) and 6-TG+UVA (red)-treated samples were analysed on a
12% gel following a pH 3–7 NL isoelectric focusing. Values indicated
correspond to the expression difference (ar) and the P-value, based on
t-tests. Protein representation was quantiﬁed using DeCyder 2D
software v6.5 (Lower panels).
Nucleic Acids Research, 2011,Vol.39, No. 12 5061labelled with 2-[
14C]-thymidine and 6-TG were UVA
irradiated. Native dsDNA and proteins have buoyant
densities of  1.7 and  1.3, respectively (19). This differ-
ence allows their clear separation on CsCl gradients.
Following cell fractionation by sequential treatments
with detergent-based extraction buffers, DNA was re-
covered and the DNA solution adjusted to a density
of 1.7 with CsCl. Gradients were centrifuged to equilib-
rium, fractionated and DNA quantiﬁed by scintillation
counting. Under these conditions, the amount of
DNA banding in the middle of the gradient correspond-
ing to the position of native, double stranded DNA
(density approximately 1.7) declined in a UVA and
6-TG-dependent fashion. An increasing proportion of
the input radioactivity was recovered in low buoyant
density fractions that also contained protein (data not
shown). In subsequent experiments, the starting density
of the gradients was adjusted to 1.40, to monitor a
possible shift in DNA density. Under these conditions,
 90% of DNA from non-irradiated cells was re-
covered in the ﬁrst gradient fractions corresponding to a
buoyant density of  1.6. UVA irradiation caused a
dose dependent increase in the fraction of DNA
banding in the middle of the gradient at a density of
around 1.4—intermediate between that of native
DNA and protein (Figure 6A). This altered buoyant
density is consistent with the covalent attachment of
protein to DNA and a similar DNA density shift was
observed in cells treated with formaldehyde, which is
known to cause DNA–protein crosslinking (Figure 6A,
top right insert).
The density shift of DNA from treated cells was
reversed by extensive protease digestion of DNA
samples before banding (proteinase K, 1mg/ml ﬁnal,
16h at 50 C). This resulted in most of the radioactive 2-
[
14C]-thymidine labelled DNA being recovered close to the
bottom of the gradient corresponding to a buoyant
density of  1.6 (Figure 6B). In contrast to the effects of
protease digestion, pre-treatment of the DNA samples
with the reducing agents b-mercaptoethanol and DTT
(10mM DTT, 1% b-mercaptoethanol, 50 C, 16h) or
with high temperature (15min at 95 C; data not shown)
before banding did not signiﬁcantly affect DNA density
(Figure 6B). This suggests that most of the protein–DNA
attachment is not via disulphide linkages. Their thermal
stability also distinguishes these photochemically induced
complexes from those generated by formaldehyde
treatment.
Control experiments conﬁrmed that the DNA–protein
crosslinks were formed within cells rather than during
DNA extraction and processing when irradiated DNA
and proteins are in intimate contact. When
6-TG-containing DNA was irradiated and mixed with
CCRF-CEM cell proteins and banded, <10% was re-
covered at the position of reduced density (data not
shown).
DNA in the vicinity of replication forks is particularly
sensitive to breakage by 6-TG/UVA (12). To determine
whether protein crosslinking exhibited a similar bias, we
performed pulse-chase experiments. CCRF-CEM cells
were allowed to incorporate 6-TG for 4h. They were
then irradiated with 50kJ/m
2 UVA either immediately
or following an additional 4h growth in 6-TG free
medium to allow replication forks to move away from
the incorporated 6-TG. In both cases,  10% of the
DNA exhibited reduced density (Supplementary
Figure S4). Thus, crosslinking appears to be likely in
any DNA regions containing 6-TG.
The UVA doses used to induce DNA–protein
crosslinking are signiﬁcantly less than one minimal
erythema dose (9) and are therefore in the physiologically
relevant range. In most experiments, cells containing an
average DNA 6-TG substitution of around 1% 6-TG:G
were used. This is more than an order of magnitude higher
than the levels found in skin of patients treated with
thiopurines (6). To assess whether patients’ skin might
be at risk for this type of DNA damage, we determined
the lowest level of DNA 6-TG at which DNA–protein
crosslinks were detectable in cultured cells. Crosslinking
was detected in irradiated cells with DNA substitution of
Actin
AB
225 225
150 150
- +      - - +      +      + 6-TG (1mM) - +      - - +      +      +
- - 10    30     5    10     30 UVA (kJ/m2) - - 10     30    5    10     30
Figure 5. 6-TG/UVA-dependent decreased recovery of nuclear MSH2. CCRF-CEM cells were treated for 48h with 6-TG and irradiated with UVA
as indicated. Triton-soluble (A) and sonicated triton-insoluble fractions (B) were analysed by western blotting using an anti-MSH2 antibody.
5062 Nucleic Acids Research, 2011,Vol.39, No. 12around 0.04% (range 0.034–0.058, n=2), which is close
to the levels of about 0.02% 6-TG:G in DNA of lympho-
cytes and skin of patients taking azathioprine (4–6). This
suggests that photochemical DNA–protein crosslink for-
mation may be a hazard for skin cells of patients on
thiopurine therapy.
DNA crosslinked DNA repair proteins
CsCl gradient fractions contain crosslinked material free
from unmodiﬁed DNA or protein. Gradient fractions
from 6-TG/UVA treated CCRF-CEM cells were applied
to nitrocellulose membranes which were then probed for
the presence of speciﬁc proteins. Figure 7 shows that two
DNA repair proteins, MSH2 and the nucleotide excision
repair (NER) factor XPA, the replication/repair factor
PCNA and the replication factor MCM2, were all signiﬁ-
cantly represented in the crosslinked DNA fraction. There
was no detectable DNA association of the largely cyto-
plasmic CASPASE 5.
DISCUSSION
The skin of patients taking thiopurines contains DNA
6-TG and is selectively sensitive to UVA radiation (6,9).
Since cutaneous photosensitivity reﬂects the formation of
DNA lesions, it is important to understand what types of
photochemical DNA damage may be produced by the
interaction of DNA 6-TG and UVA.
In view of the reactivity of DNA 6-TG and its particular
ability to form addition products with low-molecular
weight thiol compounds (10), we examined crosslinking
of proteins to DNA 6-TG. Photochemical adduction of
puriﬁed proteins to DNA containing 6-TG has previously
been demonstrated (20,21). In our in vitro experiments, we
found that G
SO3, the oxidized form of 6-TG, was a likely
intermediate in peptide crosslinking. This may, in part,
reﬂect the ability of SO3 to serve as a good leaving
group in nucleophilic substitution reactions (10). Most
of the products were susceptible to reducing treat-
ments—consistent with the formation of disulphide
bridges between the cysteine thiol and 6-TG. A minority
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Figure 6. (A) Buoyant density of DNA from 6-TG/UVA-treated cells. 6-TG-treated CCRF-CEM cells, which had been labelled with 2-[
14C]-thy-
midine, were irradiated with UVA. Genomic DNA was extracted and the solution adjusted to a density of 1.4 with CsCl. Gradients were centrifuged
to equilibrium and fractionated. Radioactivity in the fractions was measured by scintillation counting. DNA of normal density (1.70) is recovered in
the ﬁrst few fractions. (open square), No UVA; (open triangle), 5kJ/m
2; (open diamond), 10kJ/m
2; (open circle), 25kJ/m
2; (ﬁlled square), 50kJ/m
2.
Insert: DNA banding from formaldehyde-treated cells. (B) Protease sensitivity of low-density DNA fractions. DNA from 6-TG/UVA (50kJ/m
2)
treated CCRF-CEM cells was extracted and treated with Proteinase K (open square) or reducing agents (open triangle) or untreated (open circle)
before banding on CsCl. Gradients were centrifuged and fractionated as above.
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crosslinking was reduced when these were blocked by
acetylation.
DNA–protein crosslinks from UVA-irradiated cells
were largely refractory to reducing treatments. This
suggests that, unlike the in vitro crosslinks, disulphide
protein–DNA bridges are not highly represented among
these in vivo products. This may simply reﬂect the relative
concentrations of –SH and –NH2 groups in the in vitro
and in vivo experiments. Although primary amino groups
of this type are less nucleophilic than thiols, they are much
more abundant in vivo and the amino acids with a free
amino group (R, N, Q, K) represent about 20% of all
amino acids in human proteins. In contrast, the more
hydrophobic cysteine comprises only 1.7% of the total
(source: UniProtKB/Swiss-Prot protein knowledgebase,
release 2011-01). The hydrophilic nature of amino
groups also means that they are frequently exposed on
the protein surface. For these reasons, we consider it
possible that these N-bonded proteins comprise a signiﬁ-
cant fraction of the DNA 6-TG-protein crosslinks formed
in UVA-irradiated cells. We noted signiﬁcant differences
in the kinetics of crosslinking in vivo and in vitro, however.
This may partially reﬂect the structural arrangement of
the crosslinked partners. The reaction of the oligonucleo-
tide G
SO3 with the oligopeptide –SH or –NH2 groups
occurs in relatively dilute solution. In the cell, the close
proximity of DNA associated proteins to any G
SO3 that is
formed may signiﬁcantly accelerate crosslinking. An alter-
native explanation invokes a different photochemistry for
DNA 6-TG. The formation of G
SO3 is via singlet oxygen
and Type II photosensitization. It is possible that 6-TG
can also act as a Type I photosensitizer and the rapid
formation of DNA–protein crosslinks in vivo is consistent
with a free radical intermediate that can react only with
proteins in extremely close proximity. At present, we
cannot distinguish between these possibilities.
We previously demonstrated photochemical damage to
proteins in the form of inter-subunit crosslinks in the
DNA replication/repair protein PCNA (8). The vulner-
ability of PCNA was conﬁrmed in this study by a 2-D
DIGE analysis of nuclear proteins from 6-TG/
UVA-treated cells, which revealed consistent alterations
to PCNA and to a number of other DNA repair/replica-
tion related proteins, including MSH2 and MSH6. UVA
irradiation was associated with a measurable reduction in
overall recovery of nuclear MSH2. This suggests that se-
questration of this essential mismatch repair protein might
reduce repair efﬁciency. Isopycnic density gradient
analysis revealed the extensive formation of DNA–
protein crosslinks that was dependent on both 6-TG and
UVA. To our knowledge, this is the ﬁrst demonstration
that DNA 6-TG mediates photochemical DNA–protein
adduction in intact cells. Several lines of evidence
indicate that crosslinking is extensive. Even at low doses
of UVA, most of the 6-TG DNA fragments sheared to an
average size of around 15kb, become associated with
protein. Assuming a Poisson distribution, for 80% of
DNA fragments to be density shifted, (corresponding to
10kJ/m
2 UVA in Figure 6A), there will be, on average,
approximately one adducted protein for every 6kb of
DNA. Comparison of DNA 6-TG photoproduct yields
in vitro and in irradiated cells also indicates that DNA–
protein crosslinks are abundant. Following UVA irradi-
ation in vitro the known oxidation products, G
SO2 and
G
SO3, account for around 90% of photochemically des-
troyed DNA 6-TG (10). In UVA-irradiated cells, however,
up to 20–40% of DNA 6-TG is converted to as yet un-
identiﬁed photoproducts (22). At 1% DNA substitution
by 6-TG, a protein adduct would occur every 10kb of
DNA even if DNA–protein crosslinks comprise only
10% of these unidentiﬁed photoproducts. Finally, we
note that crosslinks were detectable following exposure
of cells to physiological UVA doses and at DNA substi-
tution levels approaching those found in the skin of
patients taking azathioprine. We conclude that these
lesions may contribute signiﬁcantly to the biological
effects of 6-TG/UVA.
The resolution afforded by gradients allowed us to
identify some of the proteins that are crosslinked to a
signiﬁcant extent. As expected, PCNA and MSH2,
which had previously been identiﬁed as likely targets,
were present in the crosslinked DNA fraction whereas
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Figure 7. Crosslinked DNA repair and replication proteins. Extracts of
CCRF-CEM cells treated with 6-TG (0.6mM, 48h) and UVA (20kJ/m
2)
were extracted and banded on CsCl. Fractions corresponding to high
( 1.7), medium (ca 1.4) or low ( 1.30) density were pooled, desalted
and concentrated. Approximately 500ml of a 0.35 A260 solution of each
fraction was applied to a hybond N nitrocellulose membrane that was
probed with the antibodies indicated.
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plasmic distribution, was not. This analysis was not ex-
haustive but nevertheless provides clear evidence that
DNA-related nuclear proteins are at risk of covalent
attachment to DNA. The approach has the potential
to address the unresolved question of DNA–protein
crosslink repair in human cells. There are suggestions
that smaller adducts can be removed by a mechanism
that is partially dependent on NER(23,24) In our experi-
ments, the overall removal of 6-TG-mediated crosslinks
was, at best, extremely slow and the fraction of density
shifted DNA did not change signiﬁcantly up to 24-h post
irradiation (data not shown). These observations are con-
sistent with suggestions that large DNA–protein adducts
are not efﬁciently repaired by NER. From a chemical
point of view, the protein–DNA bonds are robust and
are unaffected by extended treatment with heat, salts
and reducing agents. Indeed, it seems likely that there is
no effective method of removing these lesions and the cells
need to process the aftermath of their interaction with
replication. Consistent with this view, homologous recom-
bination plays a critical role in the tolerance of crosslinked
proteins (25,26). The more reﬁned analysis that can be
applied to the individual crosslinked proteins in the
gradient fraction will permit analysis of the fate of indi-
vidual crosslinked species.
In summary, we have demonstrated numerous alter-
ations to the nuclear proteins of UVA-irradiated cells con-
taining DNA 6-TG. These changes include a rapid and
efﬁcient formation of stable covalent DNA–protein
crosslinks. It seems likely that DNA–protein crosslinking
will inﬂuence DNA repair—either by steric hindrance pre-
venting binding and/or translocation of repair proteins or
by their physical sequestration. We have provided the ﬁrst
evidence for the latter possibility. Our ﬁndings indicate
that, overall DNA–protein crosslinks are not efﬁciently
repaired but the analysis outlined here will permit a
more detailed investigation of the fate of individual
crosslinked protein species. Any signiﬁcant interference
with DNA repair might, by reducing the efﬁciency of
excision of pro-mutagenic UVB-induced DNA lesions,
increase the potential mutagenicity of sunlight in skin of
long-term immunosuppressed patients and thereby con-
tribute to their increased skin cancer risk.
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